Page navigation1 2 3 4 5 [>>]

DuBiotech

Dubai Biotechnology and Research Park



  • DuBiotech announces partnership with BioMedix at BIO 2008 in US

  • Dubai Biotechnology and Research Park (DuBiotech), announced a partnership agreement with BioMedix Inc, a leading equipment and services provider for non invasive detection of peripheral vascular disease (PVD), to manufacture in-vitro diagnostic (IVD) equipment in Dubai.
  • United Arab Emirates: Saturday, June 21 - 2008 at 14:01
  • (From Left) G. Steven Burrill, Chairman, NewBridge Pharmaceuticals and CEO, Burrill & Company; Dr. Abdulqader Alkhayat, Executive Director, DuBiotech; and Garrett Vygantas, M.D., Co-founder and Interim CEO, NewBridge Pharmaceuticals, and Director, Burrill & Company.
  • NewBridge Pharmaceuticals launches global base at DuBiotech

  • Dubai Biotechnology and Research Park (DuBiotech), a member of TECOM Investments, signed a partnership agreement with NewBridge Pharmaceuticals, a specialty pharmaceuticals, biologics and devices company, for locating its global headquarters at the world's leading business park for the life sciences industry.
  • United Arab Emirates: Wednesday, April 30 - 2008 at 08:22
  • DuBiotech to highlight latest advancements in life sciences at PABME 2008 in Dubai

  • Dubai Biotechnology and Research Park (DuBiotech), a member of TECOM Investments and the leading business park dedicated to the global life science industry, today announced it will highlight the latest advancements in life sciences at the Pharmaceutical and Biotechnology Middle East 2008 (PABME), the first international exhibition and conference for the industry in the Middle East.
  • United Arab Emirates: Thursday, April 24 - 2008 at 11:54
  • Dr. Abdulqader Alkhayat, Executive Director of DuBiotech; Zeydan Abuissa, General Manager of Pfizer; Jeffrey B. Kindler, Chairman and CEO of Pfizer; Abdullatif Almulla, CEO of TECOM Investments; Joshua Kindler; and Marwan Abdulaziz,  Director of Sales at DuBiotech; during a meeting to discuss Pfizer's future projects at DuBiotech.
  • Pfizer to establish new regional medical and marketing headquarters in Dubai

  • Pfizer Inc, the world's premier research-based pharmaceutical company, today announced the establishment of its new medical and marketing headquarters in Dubai, licensed by Dubai Biotechnology and Research Park (DuBiotech), a member of TECOM Investments.
  • United Arab Emirates: Thursday, March 27 - 2008 at 11:38
  • From left: Abdul Salam Al Madani, President, INDEX Holding; and Dr. Abdulqader Al Khayat, Executive Director, Dubai Biotechnology and Research Park (DuBiotech), finalizing the business partnership agreement at DuBiotech's exhibition stand at Arab Lab - The Expo 2008. DuBiotech, a member of TECOM Investments, is the official patron of Arab Lab 2008, one of the largest laboratory and instrumentation industry shows in Asia and the Middle East that runs until 13 February at the Dubai International Convention and Exhibition Centre.
  • Index Holding to open regional headquarters at DuBiotech

  • Index Holding, leading organisers of medical, scientific, trade and educational conferences and exhibitions, today announced the launch of its regional headquarters at the Dubai Biotechnology and Research Park (DuBiotech), a member of TECOM Investments.
  • United Arab Emirates: Monday, February 11 - 2008 at 15:25


Index : Company News : Dubai Holding : DuBiotech
Page navigation1 2 3 4 5 [>>]

Sponsored Links

MediaCentre »

Business Directory »

News and Articles »

Current Events »

Advertisement »